Viewing Study NCT04616560

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:17 AM

Ignite Modification Date: 2025-12-27 @ 10:50 PM

Study NCT ID: NCT04616560

Status: SUSPENDED

Last Update Posted: 2025-10-31

First Post: 2020-11-04

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Trastuzumab Deruxtecan for the Treatment of HER2+ Newly Diagnosed or Recurrent Osteosarcoma

Sponsor: National Cancer Institute (NCI)

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module